|
|
|
|
Galileo CAD software identifies and marks suspect areas on digital mammograms.
Galileo CAD can assist radiologists in minimizing observational oversights, by identifying regions that may
warrant a more meticulous review.
The core technology for Galileo CAD software is patented in USA and patent pending in EU and the product fulfills
 requirements.
|
|
|
|
The potential tumor opacities detected by Galileo
CAD for digital mammography consist in suspect opacities with a
dense core or spiculated masses with a size between
3 mm and 40 mm (diameter).
|
|
|
|
The potential clusters of microcalcifications detected by our CAD consist in at least 3 microcalcifications within a 1 cm2 area.
|
|
|
|
|
Galileo CAD for digital mammography can detect nearly 90% of cancers with an average false-positive rate of
0.5 marks per image.
Masses: 80% with 0.3 false-positives per image.
Micros: 95% with 0.2 false-positives per image.
Galileo CAD exploits innovative algorithms for detecting masses and clustered
microcalcifications.
|
|
|
|
Galileo CAD can receive images from several digital mammography units (AWS) (up to 4) and
can send results to various review stations (RWS).
Galileo CAD is fully compliant with DICOM standard.
Galileo CAD has a throughput of up to 30 patients per hour.
|
|
|
|
